Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding DMK Pharmaceuticals Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of DMK: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4543−2
Shares12.9M12.9M−4.94K (0.0%)
Value$6.44M$2.55M−$3.89M (−60.4%)

New holders (5)

Institutions that held DMK Pharmaceuticals Corp at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DMK in Q3 2022
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP186,826$37.0K0.00%
Citadel Advisors LLC145,939$29.0K0.00%
Virtu Financial LLC25,970$5.00K0.00%
Janney Montgomery Scott LLC10,000$2.00K0.00%
Simplex Trading, LLC5,388$1.00K0.00%

Sold out (7)

Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DMK in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Creative Planning100,000$50.0K
UBS Group AG85,984$43.0K
HRT Financial LP27,235$13.0K
RVW Wealth, LLC19,000$10.0K
Jane Street Group, LLC17,422$9.00K
Atria Wealth Solutions, Inc.15,000$8.00K
Squarepoint Ops LLC11,122$6.00K